RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ON-DEMAND WEBINARS
A must for all clinical leaders, this webinar shares strategic, operational, regulatory, and financial benefits of a seamless CTMS and eTMF integration. Watch the webinar to find out why CTMS-eTMF integration has increasingly become imperative for sponsors and CROs around the world.
Beyond enabling data collection outside the clinic, new models are enhancing stakeholders' abilities to access more sensitive, frequent, and objective measures of Parkinson’s progression.
In an era defined by rapid disruption and technological advancement, clinical operations leaders are under increasing pressure to enhance effectiveness while managing complex strategic trade-offs.
From eRecruitment, pre-screening, eConsent, and image-based data capture, explore how a decentralized trial design helps streamline enrollment, increase patient retention, and ensure data quality.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![An Insider’s Guide To Interactive Response Technology (IRT) For Clinical Trials]( "Modern Architecture's Impact On UX In Next-Gen Interactive Response Tech")
Modern Architecture's Impact On UX In Next-Gen Interactive Response TechExplore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.
-
![GettyImages-539843648 regulations doctor]( "EDC System Provides Flexibility, Scalability For Mid-Study Changes")
EDC System Provides Flexibility, Scalability For Mid-Study ChangesDiscover the importance of using a robust, scalable, and flexible EDC solution that handles mid-study changes for even the most complex clinical trials.
-
![GettyImages-623208264 lab, research, oncology]( "eCOA In Oncology Trials: A Tool To Simplify")
eCOA In Oncology Trials: A Tool To SimplifyAccurate quality of life data is critical in oncology. eCOA unified with IRT streamlines trials, improves data collection, and enhances site user experiences across therapeutic areas.
-
![gettyimages-1374251769-170667a]( "Strong eCOA Provider And Linguistic Validation Expert Partner For Success")
Strong eCOA Provider And Linguistic Validation Expert Partner For SuccessExplore the creation and implementation of the electronic versions of COAs (eCOAs) on a high priority study with a new client.
-
![GettyImages-866433760 data]( "Achieving Self Sufficiency In Data Collection For Optinose")
Achieving Self Sufficiency In Data Collection For OptinoseUncover how this specialty pharmaceutical company was able to gain control over its EDC environment by adopting a solution their team could use in-house.
-
![AI text with circuit pattern-GettyImages-924253506]( "The Digital Teammate: How AI Is Changing Clinical Research")
The Digital Teammate: How AI Is Changing Clinical ResearchAI in clinical research serves as a "digital colleague," enhancing workflows, accelerating data analysis, and empowering study teams with precision, and insightful solutions for better patient outcomes.
-
![GettyImages-1403976499 vaccine, development]( "Accelerated Approval As The New \"Norm\" In Gene Therapy For Rare Diseases")
Accelerated Approval As The New "Norm" In Gene Therapy For Rare DiseasesGene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.
-
![electronic-medical-technology-GettyImages-1204743045]( "Broadening Eligibility Criteria Among Cancer Clinical Trials Patients")
Broadening Eligibility Criteria Among Cancer Clinical Trials PatientsThis study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.
-
![Future Digital Transformation GettyImages-1297914649]( "Study Start-Up Checklist For Digital Clinical Trials")
Study Start-Up Checklist For Digital Clinical TrialsRead how five Florence employees with clinical research backgrounds came together to craft a checklist designed to walk sites through the process of tech-enabled study start-up.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
RECENT NEWSLETTERS
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
